01.01.2005 | Clinical Study
Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study
Erschienen in: Journal of Neuro-Oncology | Ausgabe 1/2005
Einloggen, um Zugang zu erhalten